United States: Healthcare

As Congress debates federal privacy legislation and agencies pursue broader access to health records, a Fourth Circuit appeal examines whether patients and families can challenge government subpoenas for sensitive medical information.

U.S. companies conducting clinical trials in Europe face a complex regulatory landscape where GDPR data protection requirements and the Clinical Trials Regulation (CTR) must be carefully aligned. This article examines the common operational pitfalls sponsors encounter when these frameworks diverge, and explains why early coordination across legal, clinical, and data teams is essential for maintaining trial momentum and avoiding costly compliance issues.

On May 12, 2026, the Food and Drug Administration (FDA) published a notice in the Federal Register requesting comment on the agency’s efforts related to drug repurposing to help address unmet medical needs.